ITPRIPL1 and cancer: Drug sensitivity analysis and molecular docking were conducted based on data from Gene Set Cancer Analysis (GSCA), Genomics of Drug Sensitivity in Cancer (GDSC), UniProt, and PubChem databases to explore the therapeutic potential of ITPRIPL1 as a drug target.